Orchestra BioMed (OBIO) Earnings Date, Estimates & Call Transcripts

$4.71
-0.24 (-4.85%)
(As of 05/10/2024 ET)

Earnings Summary

Latest
Earnings Date
Mar. 27Estimated
Actual EPS
(Mar. 27)
-$0.37 Beat By $0.01
Consensus EPS
(Mar. 27)
-$0.38
Skip Charts & View Estimated and Actual Earnings Data

OBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

OBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Orchestra BioMed Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.48)($0.48)($0.48)
Q2 20241($0.48)($0.48)($0.48)
Q3 20241($0.49)($0.49)($0.49)
Q4 20241($0.50)($0.50)($0.50)
FY 20244($1.95)($1.95)($1.95)
Q1 20251($0.51)($0.51)($0.51)
Q2 20251($0.53)($0.53)($0.53)
Q3 20251($0.54)($0.54)($0.54)

OBIO Earnings Date and Information

Orchestra BioMed last issued its earnings results on March 27th, 2024. The reported ($0.37) earnings per share for the quarter, beating analysts' consensus estimates of ($0.38) by $0.01. The company earned $0.26 million during the quarter, compared to analyst estimates of $1 million. Orchestra BioMed has generated ($1.50) earnings per share over the last year (($1.50) diluted earnings per share). Earnings for Orchestra BioMed are expected to decrease in the coming year, from ($1.66) to ($1.78) per share.

Orchestra BioMed Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/27/2024Q4 2023($0.38)($0.37)+$0.01($0.37)$1.00 million$0.26 million
11/13/2023Q3 2023($0.39)($0.38)+$0.01($0.38)$0.89 million$0.42 million
8/10/2023Q2 2023($0.42)($0.35)+$0.07($0.35)$0.71 million$0.92 million
5/12/2023Q1 2023($0.23)($0.40)($0.17)($0.40)$0.68 million$1.16 million

Orchestra BioMed Earnings - Frequently Asked Questions

When did Orchestra BioMed announce their last quarterly earnings?

Orchestra BioMed (NASDAQ:OBIO) last announced its quarterly earning data on Wednesday, March 27, 2024. Learn more on OBIO's earnings history.

Did Orchestra BioMed beat their earnings estimates last quarter?

In the previous quarter, Orchestra BioMed (NASDAQ:OBIO) reported ($0.37) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.38) by $0.01. Learn more on analysts' earnings estimate vs. OBIO's actual earnings.

How much revenue does Orchestra BioMed generate each year?

Orchestra BioMed (NASDAQ:OBIO) has a recorded annual revenue of $2.76 million.

How much profit does Orchestra BioMed generate each year?

Orchestra BioMed (NASDAQ:OBIO) has a recorded net income of -$49.12 million. OBIO has generated -$1.50 earnings per share over the last four quarters.

What is Orchestra BioMed's EPS forecast for next year?

Orchestra BioMed's earnings are expected to decrease from ($1.66) per share to ($1.78) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:OBIO) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners